Commander Navneet Bali, a well-known healthcare executive, has been named Group CEO of ClearMedi Healthcare, a cancer-focused healthcare service provider.

Morgan Stanley has acquired a majority stake in ClearMedi Healthcare, marking its historic entry into the Indian healthcare sector. ClearMedi Healthcare, led by Commander Bali and backed by Morgan Stanley, aims to strengthen its industry position.

Commander Bali is poised to lead ClearMedi Healthcare to new heights of success after a distinguished 25-year career in the Indian Navy and successful leadership roles at Narayana Health and IOSPL.

Dr Shashi Baliyan, Founder of ClearMedi Healthcare, expressed enthusiasm about this groundbreaking collaboration, stating,

“Morgan Stanley’s entry into the Indian healthcare sector signifies a transformative moment for our industry. As we continue to expand and provide high-quality healthcare solutions to our patients, Commander Navneet Bali’s visionary leadership, coupled with Morgan Stanley’s support, will play a pivotal role in shaping our company’s future.”

Commander Bali said,

“I am honored to join ClearMedi Healthcare as the Group CEO and be part of an organization committed to making a meaningful impact in the healthcare landscape. Together with our talented team, we will drive innovation, foster growth, and ensure that ClearMedi Healthcare remains a beacon of excellence in the industry.”

Shashi Kant Baliyan founded ClearMedi Healthcare in 2010, a partnership between Medipass, KOS S.p.A., and Clearview Healthcare India.

It oversees complex clinical services, including oncology, nuclear medicine, and radiology, and operates specialized hospitals with over 350 beds across various locations. ClearMedi serves patients in eight states and a union territory, primarily excelling in cancer care.

Morgan Stanley PE Asia has acquired a controlling stake in ClearMedi Healthcare, valued at $35 million, demonstrating its commitment to India's healthcare sector, by acquiring a majority stake from Italy's KOS Group.